Upgrade to SI Premium - Free Trial

Biogen's (BIIB) Leqembi filing setback 'negative for sentiment'

April 1, 2024 6:40 AM
Biogen (NASDAQ: BIIB) shares have dipped more than 1% premarket on the back of news that the company and Eisai ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Hot List

Next Articles